112 related articles for article (PubMed ID: 37450654)
1. High-intensity interval training and thromboembolic events during chemotherapy for testicular cancer: a retrospective analysis from the
Bloomquist K; Andersen C; Munck S; Lillelund C; Lauritsen J
Acta Oncol; 2023 Jun; 62(6):666-672. PubMed ID: 37450654
[No Abstract] [Full Text] [Related]
2. Thromboembolic events after high-intensity training during cisplatin-based chemotherapy for testicular cancer: Case reports and review of the literature.
Thorsen L; Haugnes HS; Fosså SD; Brydøy M; Tandstad T; Wisløff T; Gjerset GM; Edvardsen E; Larsen KO; Sandset PM; Henriksson CE; Raastad T; Negaard HFS
Int J Cancer; 2020 Dec; 147(11):3189-3198. PubMed ID: 32525564
[TBL] [Abstract][Full Text] [Related]
3. Short-term and Long-term Feasibility, Safety, and Efficacy of High-Intensity Interval Training in Cardiac Rehabilitation: The FITR Heart Study Randomized Clinical Trial.
Taylor JL; Holland DJ; Keating SE; Leveritt MD; Gomersall SR; Rowlands AV; Bailey TG; Coombes JS
JAMA Cardiol; 2020 Dec; 5(12):1382-1389. PubMed ID: 32876655
[TBL] [Abstract][Full Text] [Related]
4. Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: A phase 2 randomized controlled trial.
Adams SC; DeLorey DS; Davenport MH; Stickland MK; Fairey AS; North S; Szczotka A; Courneya KS
Cancer; 2017 Oct; 123(20):4057-4065. PubMed ID: 28708930
[TBL] [Abstract][Full Text] [Related]
5. High-intensity interval training in cardiac rehabilitation: a multi-centre randomized controlled trial.
McGregor G; Powell R; Begg B; Birkett ST; Nichols S; Ennis S; McGuire S; Prosser J; Fiassam O; Hee SW; Hamborg T; Banerjee P; Hartfiel N; Charles JM; Edwards RT; Drane A; Ali D; Osman F; He H; Lachlan T; Haykowsky MJ; Ingle L; Shave R
Eur J Prev Cardiol; 2023 Jul; 30(9):745-755. PubMed ID: 36753063
[TBL] [Abstract][Full Text] [Related]
6. High-intensity interval training in chronic kidney disease: A randomized pilot study.
Beetham KS; Howden EJ; Fassett RG; Petersen A; Trewin AJ; Isbel NM; Coombes JS
Scand J Med Sci Sports; 2019 Aug; 29(8):1197-1204. PubMed ID: 31025412
[TBL] [Abstract][Full Text] [Related]
7. Highly favorable physiological responses to concurrent resistance and high-intensity interval training during chemotherapy: the OptiTrain breast cancer trial.
Mijwel S; Backman M; Bolam KA; Olofsson E; Norrbom J; Bergh J; Sundberg CJ; Wengström Y; Rundqvist H
Breast Cancer Res Treat; 2018 May; 169(1):93-103. PubMed ID: 29349712
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of high-intensity interval training in older adults with treatment naïve chronic lymphocytic leukemia.
MacDonald G; Sitlinger A; Deal MA; Hanson ED; Ferraro S; Pieper CF; Weinberg JB; Brander DM; Bartlett DB
Sci Rep; 2021 Nov; 11(1):23137. PubMed ID: 34848750
[TBL] [Abstract][Full Text] [Related]
9. Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature.
Weijl NI; Rutten MF; Zwinderman AH; Keizer HJ; Nooy MA; Rosendaal FR; Cleton FJ; Osanto S
J Clin Oncol; 2000 May; 18(10):2169-78. PubMed ID: 10811682
[TBL] [Abstract][Full Text] [Related]
10. Predictors of thrombosis in testicular cancer during platinum-based chemotherapy.
Paffenholz P; Grein K; Heidegger I; Nestler T; Grabbert M; Salem J; Hellmich M; Pfister D; Heidenreich A
World J Urol; 2019 Sep; 37(9):1907-1916. PubMed ID: 30547197
[TBL] [Abstract][Full Text] [Related]
11. High-intensity interval training improves cardiorespiratory fitness in cancer patients and survivors: A meta-analysis.
Wallen MP; Hennessy D; Brown S; Evans L; Rawstorn JC; Wong Shee A; Hall A
Eur J Cancer Care (Engl); 2020 Jul; 29(4):e13267. PubMed ID: 32469144
[TBL] [Abstract][Full Text] [Related]
12. Effects of school-based high-intensity interval training on body composition, cardiorespiratory fitness and cardiometabolic markers in adolescent boys with obesity: a randomized controlled trial.
Meng C; Yucheng T; Shu L; Yu Z
BMC Pediatr; 2022 Mar; 22(1):112. PubMed ID: 35232402
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and feasibility of HIIT training for university students: The Uni-HIIT RCT.
Eather N; Riley N; Miller A; Smith V; Poole A; Vincze L; Morgan PJ; Lubans DR
J Sci Med Sport; 2019 May; 22(5):596-601. PubMed ID: 30509862
[TBL] [Abstract][Full Text] [Related]
14. High-Intensity Interval Training is Safe, Feasible and Efficacious in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial.
Keating SE; Croci I; Wallen MP; Cox ER; Thuzar M; Pham U; Mielke GI; Coombes JS; Macdonald GA; Hickman IJ
Dig Dis Sci; 2023 May; 68(5):2123-2139. PubMed ID: 36538276
[TBL] [Abstract][Full Text] [Related]
15. Effect of self-tailored high-intensity interval training versus moderate-intensity continuous exercise on cardiorespiratory fitness after myocardial infarction: A randomised controlled trial.
Marcin T; Trachsel LD; Dysli M; Schmid JP; Eser P; Wilhelm M
Ann Phys Rehabil Med; 2022 Jan; 65(1):101490. PubMed ID: 33450366
[TBL] [Abstract][Full Text] [Related]
16. Within-session responses to high-intensity interval training in spinal cord injury.
Astorino TA; Thum JS
Disabil Rehabil; 2018 Feb; 40(4):444-449. PubMed ID: 27930890
[TBL] [Abstract][Full Text] [Related]
17. Effects of high-intensity interval training on vascular function in breast cancer survivors undergoing anthracycline chemotherapy: design of a pilot study.
Lee K; Kang I; Mortimer JE; Sattler F; Mack WJ; Fitzsimons LA; Salem G; Dieli-Conwright CM
BMJ Open; 2018 Jun; 8(6):e022622. PubMed ID: 29961039
[TBL] [Abstract][Full Text] [Related]
18. Two-year follow-up of the OptiTrain randomised controlled exercise trial.
Bolam KA; Mijwel S; Rundqvist H; Wengström Y
Breast Cancer Res Treat; 2019 Jun; 175(3):637-648. PubMed ID: 30915663
[TBL] [Abstract][Full Text] [Related]
19. Optimizing Training Response for Women in Cardiac Rehabilitation: A Randomized Clinical Trial.
Khadanga S; Savage PD; Pecha A; Rengo J; Ades PA
JAMA Cardiol; 2022 Feb; 7(2):215-218. PubMed ID: 34817540
[TBL] [Abstract][Full Text] [Related]
20. High-intensity exercise during chemotherapy induces beneficial effects 12 months into breast cancer survivorship.
Mijwel S; Jervaeus A; Bolam KA; Norrbom J; Bergh J; Rundqvist H; Wengström Y
J Cancer Surviv; 2019 Apr; 13(2):244-256. PubMed ID: 30912010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
